{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T03:42:57Z","timestamp":1787024577392,"version":"build-2736575974"},"reference-count":19,"publisher":"Japanese Society of Internal Medicine","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2019,3,15]]},"DOI":"10.2169\/internalmedicine.1516-18","type":"journal-article","created":{"date-parts":[[2018,11,18]],"date-time":"2018-11-18T17:33:13Z","timestamp":1542562393000},"page":"837-841","source":"Crossref","is-referenced-by-count":33,"title":["Clinical Features of Anti-MDA5 Antibody-positive Rapidly Progressive Interstitial Lung Disease without Signs of Dermatomyositis"],"prefix":"10.2169","volume":"58","author":[{"given":"Noriho","family":"Sakamoto","sequence":"first","affiliation":[{"name":"Department of Respiratory Medicine, Nagasaki University Graduate School of Biomedical Sciences, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Ishimoto","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Nagasaki University Graduate School of Biomedical Sciences, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shota","family":"Nakashima","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Nagasaki University Graduate School of Biomedical Sciences, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirokazu","family":"Yura","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Nagasaki University Graduate School of Biomedical Sciences, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuto","family":"Miyamura","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Nagasaki University Graduate School of Biomedical Sciences, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Okuno","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Nagasaki University Graduate School of Biomedical Sciences, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsuko","family":"Hara","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Nagasaki University Graduate School of Biomedical Sciences, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Kitazaki","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, The Japanese Red Cross Nagasaki Genbaku Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoyuki","family":"Kakugawa","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Nagasaki University Graduate School of Biomedical Sciences, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuji","family":"Ishimatsu","sequence":"additional","affiliation":[{"name":"Department of Cardiopulmonary Rehabilitation Science, Unit of Rehabilitation Sciences, Nagasaki University Graduate School of Biomedical Sciences, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minoru","family":"Satoh","sequence":"additional","affiliation":[{"name":"Department of Clinical Nursing, School of Health Sciences, University of Occupational and Environmental Health, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Mukae","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Nagasaki University Graduate School of Biomedical Sciences, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"publisher","unstructured":"1. Mukae H, Ishimoto H, Sakamoto N, et al. Clinical differences between interstitial lung disease associated with clinically amyopathic dermatomyositis and classic dermatomyositis. Chest 136: 1341-1347, 2009.","DOI":"10.1378\/chest.08-2740"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Satoh M, Tanaka S, Ceribelli A, Calise SJ, Chan EK. A comprehensive overview on myositis-specific antibodies: new and old biomarkers in idiopathic inflammatory myopathy. Clin Rev Allergy Immunol 52: 1-19, 2017.","DOI":"10.1007\/s12016-015-8510-y"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Sato S, Murakami A, Kuwajima A, et al. Clinical utility of an enzyme-linked immunosorbent assay for detecting anti-melanoma differentiation-associated gene 5 autoantibodies. PLoS One 11: e0154285, 2016.","DOI":"10.1371\/journal.pone.0154285"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Hamaguchi Y, Kuwana M, Hoshino K, et al. Clinical correlations with dermatomyositis-specific autoantibodies in adult Japanese patients with dermatomyositis: a multicenter cross-sectional study. Arch Dermatol 147: 391-398, 2011.","DOI":"10.1001\/archdermatol.2011.52"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Tamai K, Tachikawa R, Otsuka K, Ueda H, Hosono Y, Tomii K. Early pulmonary involvement of anti-CADM-140 autoantibody-positive rapidly progressive interstitial lung disease preceding typical cutaneous symptoms. Intern Med 53: 2515-2519, 2014.","DOI":"10.2169\/internalmedicine.53.2769"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Ortiz-Santamaria V, Babot A, Ferrer C. Anti-MDA5-positive dermatomyositis: an emerging entity with a variable clinical presentation. Scand J Rheumatol 46: 509-511, 2017.","DOI":"10.1080\/03009742.2017.1340512"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Gonzalez-Moreno J, Raya-Cruz M, Losada-Lopez I, Cacheda AP, Oliver C, Colom B. Rapidly progressive interstitial lung disease due to anti-MDA5 antibodies without skin involvement: a case report and literature review. Rheumatol Int 38: 1293-1296, 2018.","DOI":"10.1007\/s00296-018-3991-7"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Travis WD, Costabel U, Hansell DM, et al. An official American Thoracic Society\/European Respiratory Society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med 188: 733-748, 2013.","DOI":"10.1164\/rccm.201308-1483ST"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Chino H, Sekine A, Baba T, et al. Radiological and pathological correlation in anti-MDA5 antibody-positive interstitial lung disease: rapidly progressive perilobular opacities and diffuse alveolar damage. Intern Med 55: 2241-2246, 2016.","DOI":"10.2169\/internalmedicine.55.5774"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Tanizawa K, Handa T, Nakashima R, et al. HRCT features of interstitial lung disease in dermatomyositis with anti-CADM-140 antibody. Respir Med 105: 1380-1387, 2011.","DOI":"10.1016\/j.rmed.2011.05.006"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Ikeda S, Arita M, Morita M, et al. Interstitial lung disease in clinically amyopathic dermatomyositis with and without anti-MDA-5 antibody: to lump or split? BMC Pulm Med 15: 159, 2015.","DOI":"10.1186\/s12890-015-0154-4"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Koga T, Fujikawa K, Horai Y, et al. The diagnostic utility of anti-melanoma differentiation-associated gene 5 antibody testing for predicting the prognosis of Japanese patients with DM. Rheumatology (Oxford) 51: 1278-1284, 2012.","DOI":"10.1093\/rheumatology\/ker518"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Gono T, Sato S, Kawaguchi Y, et al. Anti-MDA5 antibody, ferritin and IL-18 are useful for the evaluation of response to treatment in interstitial lung disease with anti-MDA5 antibody-positive dermatomyositis. Rheumatology (Oxford) 51: 1563-1570, 2012.","DOI":"10.1093\/rheumatology\/kes102"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Matsushita T, Mizumaki K, Kano M, et al. Antimelanoma differentiation-associated protein 5 antibody level is a novel tool for monitoring disease activity in rapidly progressive interstitial lung disease with dermatomyositis. Br J Dermatol 176: 395-402, 2017.","DOI":"10.1111\/bjd.14882"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Ma X, Chen Z, Hu W, et al. Clinical and serological features of patients with dermatomyositis complicated by spontaneous pneumomediastinum. Clin Rheumatol 35: 489-493, 2016.","DOI":"10.1007\/s10067-015-3001-3"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Nakashima R, Mimori T. [Anti-MDA5 (melanoma differentiation-associated gene 5) antibody and dermatomyositis with rapidly progressive interstitial pneumonia]. Nihon Rinsho Meneki Gakkai Kaishi 36: 71-76, 2013 (in Japanese, Abstract in English).","DOI":"10.2177\/jsci.36.71"},{"key":"17","doi-asserted-by":"publisher","unstructured":"17. Nakashima R, Hosono Y, Mimori T. Clinical significance and new detection system of autoantibodies in myositis with interstitial lung disease. Lupus 25: 925-933, 2016.","DOI":"10.1177\/0961203316651748"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Kurasawa K, Arai S, Namiki Y, et al. Tofacitinib for refractory interstitial lung diseases in anti-melanoma differentiation-associated 5 gene antibody-positive dermatomyositis. Rheumatology (Oxford) 2018 (Epub ahead of print).","DOI":"10.1093\/rheumatology\/key188"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. So H, Wong VTL, Lao VWN, Pang HT, Yip RML. Rituximab for refractory rapidly progressive interstitial lung disease related to anti-MDA5 antibody-positive amyopathic dermatomyositis. Clin Rheumatol 37: 1983-1989, 2018.","DOI":"10.1007\/s10067-018-4122-2"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/58\/6\/58_1516-18\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,3,16]],"date-time":"2019-03-16T01:34:00Z","timestamp":1552700040000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/58\/6\/58_1516-18\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,15]]},"references-count":19,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.1516-18","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,15]]}}}